Skip to main content

Advertisement

Log in

Evaluation of myeloperoxidase in synovial fluid as a biomarker for chronic periprosthetic joint infection

  • Original Paper
  • Published:
International Orthopaedics Aims and scope Submit manuscript

Abstract

Purpose

There is no single biomarker that can perfectly diagnose periprosthetic joint infection (PJI). As diagnosing PJI remains a major challenge, accurate and rapid development of a biomarker is required. Myeloperoxidase (MPO) is a bactericidal enzyme that acts against pathogenic microorganisms, such as those found in PJI. We aimed to determine whether elevated MPO levels could be detected in infected synovial fluid and to evaluate its utility as a biomarker for diagnosing chronic PJI.

Methods

Patients who underwent revision total joint arthroplasty were categorised into two groups according to the criteria of the second International Consensus Meeting on Musculoskeletal Infection: chronic PJI or aseptic failure. MPO was measured in synovial fluid collected during surgery. Receiver operating characteristic curves were drawn, and the area under the curve, 95% confidence intervals, and sensitivity/specificity were calculated.

Results

Synovial fluid was obtained from 37 patients. Nineteen patients were categorised into the chronic PJI group and 18 in the aseptic failure group. MPO levels in the synovial fluid were significantly higher in the chronic PJI group than in the aseptic failure group (p < 0.001). This measurement demonstrated the diagnostic accuracy of MPO for diagnosing chronic PJI with high sensitivity and specificity.

Conclusion

Although the results are debatable owing to the small sample size, measurement of MPO demonstrates high accuracy as a biomarker for diagnosing chronic PJI, and it may detect culture-negative chronic PJI. Furthermore, MPO can measure host response to chronic PJI without the potential of contamination.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Darouiche RO (2004) Infections associated with surgical implants. N Engl J Med 351:193–195. https://doi.org/10.1056/NEJMra035415

    Article  Google Scholar 

  2. Lee YS, Koo K-H, Kim HJ, Tian S, Kim T-Y, Maltenfort MG, Chen AF (2017) Synovial fluid biomarkers for the diagnosis of periprosthetic joint infection. J Bone Jt Surg 99:2077–2084. https://doi.org/10.2106/JBJS.17.00123

    Article  Google Scholar 

  3. Choi H-R, Kwon Y-M, Freiberg AA, Nelson SB, Malchau H (2013) Periprosthetic joint infection with negative culture results: clinical characteristics and treatment outcome. J Arthroplast 28:899–903. https://doi.org/10.1016/j.arth.2012.10.022

    Article  Google Scholar 

  4. Hansson M, Olsson I, Nauseef WM (2006) Biosynthesis, processing, and sorting of human myeloperoxidase. Arch Biochem Biophys 445:214–224. https://doi.org/10.1016/j.abb.2005.08.009

    Article  CAS  PubMed  Google Scholar 

  5. Dale DC, Boxer L, Liles WC (2008) The phagocytes: neutrophils and monocytes. Blood 112:935–946. https://doi.org/10.1182/blood-2007-12-077917

    Article  CAS  PubMed  Google Scholar 

  6. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Yvette Weinrauch AZ (2004) Neutrophil extracellular traps kill bacteria. Science 303:1532–1535. https://doi.org/10.1126/science.1092385

    Article  CAS  PubMed  Google Scholar 

  7. Parker H, Albrett AM, Kettle AJ, Winterbourn CC (2012) Myeloperoxidase associated with neutrophil extracellular traps is active and mediates bacterial killing in the presence of hydrogen peroxide. J Leukoc Biol 91:369–376. https://doi.org/10.1189/jlb.0711387

    Article  CAS  PubMed  Google Scholar 

  8. Schwarz EM, Parvizi J, Gehrke T, Aiyer A, Battenberg A, Brown SA et al (2019) 2018 International Consensus Meeting on Musculoskeletal Infection: research priorities from the general assembly questions. J Orthop Res 37:997–1006. https://doi.org/10.1002/jor.24293

    Article  PubMed  Google Scholar 

  9. Shohat N, Bauer T, Buttaro M, Budhiparama N, Cashman J, Della Valle CJ, Drago L, Gehrke T, Marcelino GL, Goswami K, Hailer NP (2019) Hip and knee section, what is the definition of a periprosthetic joint infection (PJI) of the knee and the hip? Can the same criteria be used for both joints?: Proceedings of International Consensus on Orthopedic Infections. J Arthroplast 34:S325–S3257. https://doi.org/10.1016/j.arth.2018.09.045

    Article  Google Scholar 

  10. Faul F, Erdfelder E, Lang AG, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175–191. https://doi.org/10.3758/BF03193146

    Article  PubMed  Google Scholar 

  11. Kanda Y (2012) Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant 48:452–458. https://doi.org/10.1038/bmt.2012.244

    Article  PubMed  PubMed Central  Google Scholar 

  12. Berbari EF, Marculescu C, Sia I, Lahr BD, Hanssen AD, Steckelberg JM, Gullerud R, Osmon DR (2007) Culture-negative prosthetic joint infection. Clin Infect Dis 45:1113–1119. https://doi.org/10.1086/522184

    Article  PubMed  Google Scholar 

  13. Deirmengian C, Kardos K, Kilmartin P, Cameron A, Schiller K, Parvizi J (2014) Diagnosing periprosthetic joint infection: has the era of the biomarker arrived? Clin Orthop Relat Res 472:3254–3262. https://doi.org/10.1007/s11999-014-3543-8

    Article  PubMed  PubMed Central  Google Scholar 

  14. Ahmad SS, Hirschmann MT, Becker R, Shaker A, Ateschrang A, Keel MJ, Albers CE, Buetikofer L, Maqungo S, Stöckle U, Kohl S (2018) A meta-analysis of synovial biomarkers in periprosthetic joint infection: Synovasure™ is less effective than the ELISA-based alpha-defensin test. Knee Surg Sport Traumatol Arthrosc 26:3039–3047. https://doi.org/10.1007/s00167-018-4904-8

    Article  Google Scholar 

  15. Zimmerli W, Lew PD, Waldvogel FA (1984) Pathogenesis of foreign body infection. Evidence for a local granulocyte defect. J Clin Invest 73:1191–1200. https://doi.org/10.1172/JCI111305

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Hasmann A, Wehrschütz-Sigl E, Marold A, Wiesbauer H, Schoeftner R, Geweßler U, Kandelbauer A, Schiffer D, Schneider KP, Binder B, Schintler M (2013) Analysis of myeloperoxidase activity in wound fluids as a marker of infection. Ann Clin Biochem 50:245–254. https://doi.org/10.1258/acb.2011.010249

    Article  CAS  PubMed  Google Scholar 

  17. Ciragil P, Kurutas EB, Miraloglu M (2014) New markers: urine xanthine oxidase and myeloperoxidase in the early detection of urinary tract infection. Dis Markers 2014:269362. https://doi.org/10.1155/2014/269362

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Wauters J, Pille F, Martens A, Franck T, Serteyn D, Gasthuys F, Meyer E (2013) Equine myeloperoxidase: a novel biomarker in synovial fluid for the diagnosis of infection. Equine Vet J 45:278–283. https://doi.org/10.1111/j.2042-3306.2012.00682.x

    Article  CAS  PubMed  Google Scholar 

  19. Baldus S, Heeschen C, Meinertz T, Zeiher AM, Eiserich JP, Münzel T, Simoons ML, Hamm CW (2003) Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108:1440–1445. https://doi.org/10.1161/01.CIR.0000090690.67322.51

    Article  CAS  PubMed  Google Scholar 

  20. Lau D, Baldus S (2006) Myeloperoxidase and its contributory role in inflammatory vascular disease. Pharmacol Ther 111:16–26. https://doi.org/10.1016/j.pharmthera.2005.06.023

    Article  CAS  PubMed  Google Scholar 

  21. Rudolph V, Andrié RP, Rudolph TK, Friedrichs K, Klinke A, Hirsch-Hoffmann B, Schwoerer AP, Lau D, Fu X, Klingel K, Sydow K (2010) Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Nat Med 16:470–474. https://doi.org/10.1038/nm.2124

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Gray E, Thomas TL, Betmouni S, Scolding N, Love S (2008) Elevated myeloperoxidase activity in white matter in multiple sclerosis. Neurosci Lett 444:195–198. https://doi.org/10.1016/j.neulet.2008.08.035

    Article  CAS  PubMed  Google Scholar 

  23. Reynolds WF, Rhees J, Maciejewski D, Paladino T, Sieburg H, Maki RA, Masliah E (1999) Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer’s disease. Exp Neurol 155:31–41. https://doi.org/10.1006/exnr.1998.6977

    Article  CAS  PubMed  Google Scholar 

  24. Swirski FK, Wildgruber M, Ueno T, Figueiredo JL, Panizzi P, Iwamoto Y, Zhang E, Stone JR, Rodriguez E, Chen JW, Pittet MJ (2010) Myeloperoxidase-rich Ly-6C+ myeloid cells infiltrate allografts and contribute to an imaging signature of organ rejection in mice. J Clin Invest 120:2627–2634. https://doi.org/10.1172/JCI42304

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Stamp LK, Khalilova I, Tarr JM, Senthilmohan R, Turner R, Haigh RC, Winyard PG, Kettle AJ (2012) Myeloperoxidase and oxidative stress in rheumatoid arthritis. Rheumatol (United Kingdom) 51:1796–1803. https://doi.org/10.1093/rheumatology/kes193

    Article  CAS  Google Scholar 

  26. McDonnell B, Hearty S, Finlay WJJ, O’Kennedy R (2011) A high-affinity recombinant antibody permits rapid and sensitive direct detection of myeloperoxidase. Anal Biochem 410:1–6. https://doi.org/10.1016/j.ab.2010.09.039

    Article  CAS  PubMed  Google Scholar 

  27. Goiffon RJ, Martinez SC, Piwnica-Worms D (2015) A rapid bioluminescence assay for measuring myeloperoxidase activity in human plasma. Nat Commun 6:6271. https://doi.org/10.1038/ncomms7271

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank Editage (www.editage.com) for English language editing.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Katsufumi Uchiyama, Yojiro Minegishi, and Shinsuke Ikeda. The first draft of the manuscript was written by Shinsuke Ikeda and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Shinsuke Ikeda.

Ethics declarations

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee (Kitasato University Medical Ethics Organization, KMEO B16-68) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ikeda, S., Uchiyama, K., Minegishi, Y. et al. Evaluation of myeloperoxidase in synovial fluid as a biomarker for chronic periprosthetic joint infection. International Orthopaedics (SICOT) 44, 1915–1920 (2020). https://doi.org/10.1007/s00264-020-04753-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00264-020-04753-0

Keywords

Navigation